ReAlta Life Sciences, Inc. Doses First Patient in Phase 1b Inhaled-LPS Challenge Clinical Trial to Support Development of RLS-0071 in Severe Asthma

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Norfolk ,Virginia ,United States ,Germany ,Hannover ,Niedersachsen ,Dburns Mcclellan ,Robert Flamm ,Kenji Cunnion ,Eric Ando ,Realta Life Sciences Inc ,European Medicines Agency ,Drug Administration ,Fraunhofer Institute For Toxicology ,Malta Life Sciences ,Chief Medical Officer ,Fraunhofer Institute ,Experimental Medicine ,Orphan Drug Designation ,Media Contact ,Realta Life Sciences ,Business Wire ,Health ,Clinical Trials ,Asthma ,